Fibrocontractive müller cell phenotypes in proliferative diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 4, 2009, Pages 1929-1939

  Guidry, Clyde ^a   King, Jeffery L ^a   Mason III, John O ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUTAMATE AMMONIA LIGASE; VIMENTIN; ACTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; MUELLER CELL; NERVE CELL CULTURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SWINE; ANIMAL; CELL CULTURE; CELL SEPARATION; FIBROBLAST; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GLIA; METABOLISM; PATHOLOGY; WESTERN BLOTTING;

ACTINS; ANIMALS; BLOTTING, WESTERN; CELL SEPARATION; CELLS, CULTURED; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUTAMATE-AMMONIA LIGASE; MICROSCOPY, FLUORESCENCE; NEUROGLIA; PHENOTYPE; SWINE; VIMENTIN;

EID: 64049099101     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2475     Document Type: Article

References (38)

1. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350(1):48-58.
2. Guidry C. The role of Muller cells in fibrocontractive retinal disorders. Prog Retin Eye Res. 2005;24(1):75-86.
3. Sramek SJ, Wallow IH, Stevens TS, et al. Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmology. 1989;96(6):835-841.
4. Hosoda Y, Okada M, Matsumura M, et al. Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study. Ophthalmic Res. 1993;25(5):289-294.
5. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes. 1998;47(3):445-449.
6. Esser P, Heimann K, Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol. 1993;77(11):731-733.
7. Weller M, Esser P, Heimann K, et al. Idiopathic proliferative vitreoretinopathy: activation of microglial cells as the deciding factor [in German]. Ophthalmologe. 1992;89(5):387-390.
8. Hiscott P, Gray R, Grierson I, et al. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol. 1994;78(3):219-222.
9. Arora PD, McCulloch CA. Dependence of collagen remodeling on alpha-smooth muscle actin expression by fibroblasts. J Cell Physiol. 1994;159:161-175.
10. Walshe R, Esser P, Wiedemann P, et al. Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol. 1992;76(9):550-552.
11. Bochaton-Piallat ML, Kapetanios AD, Donati G, et al. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibro-blast of vitreoretinopathy. Invest Ophthalmol Vis Sci. 2000;41(8): 2336-2342.
12. Hinton DR, Spee C, He S, et al. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care. 2004;27(3):758-764.
13. Kampik A, Kenyon KR, Michels RG, et al. Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol. 1981;99(8):1445-1454.
14. Gamulescu MA, Chen Y, He S, et al. Transforming growth factor 2-induced myofibroblastic differentiation of human retinal pig-ment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res. 2006;83(1):212-222.
15. Guidry C. Tractional force generation by porcine Muller cells: development and differential stimulation by growth factors. Invest Ophthalmol Vis Sci. 1997;38(2):456-468.
16. Guidry C. Isolation and characterization of porcine Muller cells: myofibroblastic dedifferentiation in culture. Invest Ophthalmol Vis Sci. 1996;37(5):740-752.
17. King JL, Guidry C. Muller cell production of insulinlike growth factor binding proteins in vitro: modulation with phenotype and growth factor stimulation. Invest Ophthalmol Vis Sci. 2004; 45(12):4535-4542.
18. Guidry C, Bradley KM, King JL. Tractional force generation by human Muller cells: growth factor responsiveness and integrin receptor involvement. Invest Ophthalmol Vis Sci. 2003;44(3): 1355-1363.
19. Nork TM, Wallow IH, Sramek SJ, et al. Muller's cell involvement in proliferative diabetic retinopathy. Arch Ophthalmol. 1987; 105(10):1424-1429.
20. Guerin CJ, Wolfshagen RW, Eifrig DE, et al. Immunocytochemical identification of Muller's glia as a component of human epiretinal membranes. Invest Ophthalmol Vis Sci. 1990;31(8):1483-1491.
21. Ohira A, de Juan E Jr. Characterization of glial involvement in proliferative diabetic retinopathy. Ophthalmologica. 1990;201(4): 187-195.
22. Molitor R, Esser P, Weller M, et al. Contractile elements in proliferative retinal diseases [in German]. Ophthalmologe. 1992;89(1): 34-38.
23. Hiscott PS, Grierson I, Trombetta CJ, et al. Retinal and epiretinal glia-an immunohistochemical study. Br J Ophthalmol. 1984; 68(10):698-707.
24. Wen R, Song Y, Cheng T, et al. Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J Neurosci. 1995;15(11): 7377-7385.
25. Amin RH, Frank RN, Kennedy A, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38(1):36-47.
26. Cao W, Wen R, Li F, et al. Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina. Exp Eye Res. 1997; 65(2):241-248.
27. Abu El-Asrar AM, Desmet S, Meersschaert A, et al. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol. 2001; 132(4):551-556.
28. Guidry C, Feist R, Morris R, et al. Changes in IGF activities in human diabetic vitreous. Diabetes. 2004;53(9):2428-2435.
29. Du Y, Sarthy VP, Kern TS. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol. 2004; 287(4):R735-R741.
30. Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest Ophthalmol Vis Sci. 2004; 45(5):1553-1561.
31. Layton CJ, Becker S, Osborne NN. The effect of insulin and glucose levels on retinal glial cell activation and pigment epithelium-derived fibroblast growth factor-2. Mol Vis. 2006;12:43-54.
32. Shelton MD, Kern TS, Mi JJ, et al. Glutaredoxin regulates nuclear factor B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy. J Biol Chem. 2007;282(17):12467-12474.
33. Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes. 2008;57(7):1952-1965.
34. Zhan X, Du Y, Crabb JS, et al. Targets of tyrosine nitration in diabetic rat retina. Mol Cell Proteomics. 2008;7(5):864-874.
35. Sarthy VP, Brodjian SJ, Dutt K, et al. Establishment and characterization of a retinal Muller cell line. Invest Ophthalmol Vis Sci. 1998;39(1)
36. Xi X, Gao L, Hatala DA, et al. Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Muller cells. Biochem Biophys Res Commun. 2005;326(3):548-553.
37. Harada C, Okumura A, Namekata K, et al. Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathy. Diabetes Res Clin Pract. 2006;74(3):249-256.
38. Brooks SE, Gu X, Kaufmann PM, et al. Modulation of VEGF production by pH and glucose in retinal Muller cells. Curr Eye Res. 1998;17(9):875-882.